World

EU drug regulator: Atypical blood clot is ‘very uncommon AstraZeneca aspect impact’

At a press briefing, EMA executive director Emer Cooke said that the combination of blood clots and low blood platelets was very rare but was seen in “all ages, and in men and women”, and there was no available evidence of “specific risk factors such as age, gender, or previous medical history of clotting disorders”.

Read More: https://www.kbcchannel.tv | For More World News | Visit Our Facebook & Twitter @kbcchanneltv | Making The Invisible, Visible

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button
%d bloggers like this: